Plaisance Capital Management
North America, Massachusetts, United States, Natick
Description
Plaisance Capital Management identifies and invests in biotechnology startups.
Investor Profile
Plaisance Capital Management has made 10 investments, with 1 in the past 12 months and 10% as lead.
Stage Focus
- Series B (30%)
- Series A (30%)
- Seed (30%)
- Series C (10%)
Country Focus
- United States (80%)
- Canada (10%)
- China (10%)
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Industry Focus
- Biotechnology
- Pharmaceutical
- Health Care
- Medical
- Oncology
- Therapeutics
- Health Diagnostics
- Medical Device
- Manufacturing
- Biopharma
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(60)'/%3e%3ccircle r='17' fill='%23000095'/%3e%3ccircle r='15' fill='%23fff'/%3e%3c/svg%3e)
